Skip Navigation


Rheumatology Advance Access originally published online on April 16, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/7/870    most recent
keg240v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pridgeon, C.
Right arrow Articles by Moots, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pridgeon, C.
Right arrow Articles by Moots, R. J.
Related Collections
Right arrow Immunogenetics
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 870-878
© 2003 British Society for Rheumatology

Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype

C. Pridgeon1,2,*, G. P. Lennon1,*, L. Pazmany1, R. N. Thompson1, S. E. Christmas2 and R. J. Moots1,

1 Academic Rheumatology Unit and
2 Department of Immunology, University of Liverpool, Liverpool, UK

Background. Natural killer (NK) cells play an important role in several animal models of autoimmunity by modulating T-cell responses, but it is unclear whether human NK cells have similar functions.

Methods. We characterized the phenotype of NK cells in synovial fluid (SF) and peripheral blood (PB) of patients with rheumatoid arthritis (RA) and in healthy control subjects using flow cytometry and quantitative PCR.

Results. The proportions of NK cells in PB and SF of RA patients were not significantly different from those in healthy PB. However, the SF NK cell phenotype was strikingly different, with increased CD94 and CD56 densities and greatly reduced proportions of cells expressing CD158a/b. These cells also had reduced mRNAs coding for CD158a/b and low perforin levels compared with RA PB and healthy PB NK cells.

Conclusions. We identified a novel phenotype of SF NK cells that is of potential significance in RA. Experiments are now under way to determine the function of these SF NK cells and their potential role in RA.

KEY WORDS: NK cells, Rheumatoid arthritis, Synovial fluid, Killer immunoglobulin-like receptors, CD158, CD94.

Correspondence to: R. J. Moots, University of Liverpool Academic Rheumatology Unit, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK. E-mail: rjmoots{at}liv.ac.uk

* C. Pridgeon and G. P. Lennon contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Harlin, M. Hanson, C. C. Johansson, D. Sakurai, I. Poschke, H. Norell, K.-J. Malmberg, and R. Kiessling
The CD16 CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset
J. Immunol., October 1, 2007; 179(7): 4513 - 4519.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
C. Beeton and K. G. Chandy
Potassium Channels, Memory T Cells, and Multiple Sclerosis
Neuroscientist, December 1, 2005; 11(6): 550 - 562.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Kitaya, T. Yamaguchi, and H. Honjo
Central Role of Interleukin-15 in Postovulatory Recruitment of Peripheral Blood CD16(-) Natural Killer Cells into Human Endometrium
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2932 - 2940.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. D. Lieto, F. Borrego, C.-h. You, and J. E. Coligan
Human CD94 Gene Expression: Dual Promoters Differing in Responsiveness to IL-2 or IL-15
J. Immunol., November 15, 2003; 171(10): 5277 - 5286.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.